glp-1 news today 2025 november 6 Insurance coverage just changed for as many as 56 million Americans when it comes to the popular medications used to promote weight loss. https://www.wfla.com/news/national/glp-1-insurance-change-impacts-millions-of-americans-what-to-know-how-to GLP-1 agonists and changes in

High caution: active diabetes on multiple medications People with type 2 diabetes who are actively taking insulin, sulfonylureas, or SGLT2 inhibitors alongside semaglutide face significantly elevated hypoglycemia and euDKA risk when adding keto

Many people take multiple medicines daily but did you know some combinations can be harmful

Injection technique and site rotation matter for optimal absorption

12-week cycle

Coverage of Semaglutide (Wegovy) by Blue Cross Blue Shield of Texas General Rules and Requirements Want to try immunotherapy

Cosmos Study May 1, 2024 Dual-Team Study Team A:Kersten Bartelt, RNJoe Deckert, PhD Team B:Steve Allen, MDBrendan Joyce Key Findings Diabetic patients prescribed four of the five glucagon-like peptide-1 receptor agonist (GLP-1) medications studied experienced increased likelihood of delayed gastric emptying (gastroparesis) compared to those not on a GLP-1 medication